相似文献
1
ZNF668 functions as a tumor suppressor by regulating p53 stability and function in breast cancer.
Cancer Res. 2011 Oct 15;71(20):6524-34. doi: 10.1158/0008-5472.CAN-11-0853. Epub 2011 Aug 18.
2
BRIT1 regulates p53 stability and functions as a tumor suppressor in breast cancer.
Carcinogenesis. 2013 Oct;34(10):2271-80. doi: 10.1093/carcin/bgt190. Epub 2013 Jun 1.
3
UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
J Pathol. 2015 Mar;235(4):656-67. doi: 10.1002/path.4478. Epub 2015 Jan 7.
4
Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Cell Death Dis. 2021 Oct 14;12(10):945. doi: 10.1038/s41419-021-04208-3.
5
TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Mol Cancer Res. 2008 Jan;6(1):64-77. doi: 10.1158/1541-7786.MCR-07-0005.
6
Regulation of Mdm2 protein stability and the p53 response by NEDD4-1 E3 ligase.
Oncogene. 2015 Jan 15;34(3):281-9. doi: 10.1038/onc.2013.557. Epub 2014 Jan 13.
7
Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.
EBioMedicine. 2019 Oct;48:248-263. doi: 10.1016/j.ebiom.2019.08.070. Epub 2019 Sep 11.
8
RFWD3-Mdm2 ubiquitin ligase complex positively regulates p53 stability in response to DNA damage.
Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4579-84. doi: 10.1073/pnas.0912094107. Epub 2010 Feb 19.
9
ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
EMBO J. 2009 Dec 16;28(24):3857-67. doi: 10.1038/emboj.2009.294.
10
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
EMBO J. 2005 Oct 5;24(19):3411-22. doi: 10.1038/sj.emboj.7600812. Epub 2005 Sep 15.
引用本文的文献
1
ZNF468-mediated epigenetic upregulation of VEGF-C facilitates lymphangiogenesis and lymphatic metastasis in ESCC via PI3K/Akt and ERK1/2 signaling pathways.
Cell Oncol (Dordr). 2024 Oct;47(5):1927-1942. doi: 10.1007/s13402-024-00976-0. Epub 2024 Aug 14.
2
Relationship between the Reduced Expression of Zinc Finger Protein 668 in Bladder Cancer and Its Invasiveness.
Int J Mol Sci. 2023 May 12;24(10):8668. doi: 10.3390/ijms24108668.
3
Nucleolar URB1 ensures 3' ETS rRNA removal to prevent exosome surveillance.
Nature. 2023 Mar;615(7952):526-534. doi: 10.1038/s41586-023-05767-5. Epub 2023 Mar 8.
4
Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer.
Am J Cancer Res. 2022 Sep 15;12(9):4373-4398. eCollection 2022.
5
Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer.
Front Oncol. 2022 Apr 4;11:784985. doi: 10.3389/fonc.2021.784985. eCollection 2021.
6
Bcl2l10 induces metabolic alterations in ovarian cancer cells by regulating the TCA cycle enzymes SDHD and IDH1.
Oncol Rep. 2021 Apr;45(4). doi: 10.3892/or.2021.7998. Epub 2021 Mar 2.
7
The HMGB1-2 Ovarian Cancer Interactome. The Role of HMGB Proteins and Their Interacting Partners MIEN1 and NOP53 in Ovary Cancer and Drug-Response.
Cancers (Basel). 2020 Aug 27;12(9):2435. doi: 10.3390/cancers12092435.
8
Downregulation of ZNF365 by methylation predicts poor prognosis in patients with colorectal cancer by decreasing phospho-p53 (Ser15) expression.
Oncol Lett. 2020 Oct;20(4):85. doi: 10.3892/ol.2020.11946. Epub 2020 Aug 5.
9
Zinc-finger protein p52-ZER6 accelerates colorectal cancer cell proliferation and tumour progression through promoting p53 ubiquitination.
EBioMedicine. 2019 Oct;48:248-263. doi: 10.1016/j.ebiom.2019.08.070. Epub 2019 Sep 11.
10
Delineating the HMGB1 and HMGB2 interactome in prostate and ovary epithelial cells and its relationship with cancer.
Oncotarget. 2018 Apr 10;9(27):19050-19064. doi: 10.18632/oncotarget.24887.
本文引用的文献
1
Rak functions as a tumor suppressor by regulating PTEN protein stability and function.
Cancer Cell. 2009 Apr 7;15(4):304-14. doi: 10.1016/j.ccr.2009.02.012.
2
Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines.
Nucleic Acids Res. 2009 Jan;37(Database issue):D925-32. doi: 10.1093/nar/gkn730. Epub 2008 Oct 15.
3
NUMB controls p53 tumour suppressor activity.
Nature. 2008 Jan 3;451(7174):76-80. doi: 10.1038/nature06412.
4
The genomic landscapes of human breast and colorectal cancers.
Science. 2007 Nov 16;318(5853):1108-13. doi: 10.1126/science.1145720. Epub 2007 Oct 11.
5
Depletion of the nucleolar protein nucleostemin causes G1 cell cycle arrest via the p53 pathway.
Mol Biol Cell. 2007 Jul;18(7):2630-5. doi: 10.1091/mbc.e07-03-0244. Epub 2007 May 9.
6
The consensus coding sequences of human breast and colorectal cancers.
Science. 2006 Oct 13;314(5797):268-74. doi: 10.1126/science.1133427. Epub 2006 Sep 7.
7
Balancing Mdm2 - a Daxx-HAUSP matter.
Nat Cell Biol. 2006 Aug;8(8):790-1. doi: 10.1038/ncb0806-790.
8
A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
Biochemistry. 2006 Aug 1;45(30):9238-45. doi: 10.1021/bi060661u.
9
Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
Mol Cell. 2006 Jul 21;23(2):251-63. doi: 10.1016/j.molcel.2006.05.029.
10
Regulation of the MDM2-p53 pathway by ribosomal protein L11 involves a post-ubiquitination mechanism.
J Biol Chem. 2006 Aug 25;281(34):24304-13. doi: 10.1074/jbc.M602596200. Epub 2006 Jun 27.
Zotero 插件